Research Combinations Discussed in the Literature AOD-9604 is sometimes discussed alongside Tesamorelin or BPC-157 in research contexts, but the rationale behind pairing these compounds is mechanistic complementarity, not a validated combination protocol no published clinical trial has tested AOD-9604 combined with either compound
Reactions are more likely during the intensive loading phase simply because the doses are close together
Prescription requires licensed clinician approval if deemed medically appropriate
Retatrutide extends the same class further as a triple receptor agonist, targeting the GLP-1, GIP, and glucagon receptors together, with the added glucagon activity aimed at boosting energy expenditure alongside appetite suppression
Vitamin B12 Injection IM Dose for Long-term Maintenance After the first treatment, shots are given less often
The addition of B12 helps combat fatigue and enhance focus